- Home
- FMNB vs FDMT Comparison
FMNB vs FDMT Comparison
Compare FMNB & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMNB | FDMT |
|---|---|---|
| Founded | 1887 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.3M | 513.6M |
| IPO Year | 2010 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FMNB | FDMT |
|---|---|---|
| Price | $12.38 | $8.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $14.33 | ★ $32.40 |
| AVG Volume (30 Days) | 441.8K | ★ 682.5K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.45% | N/A |
| EPS Growth | ★ 18.85 | N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $279,922,000.00 | $37,000.00 |
| Revenue This Year | $52.63 | $21,227.03 |
| Revenue Next Year | $8.28 | $161.87 |
| P/E Ratio | $8.60 | ★ N/A |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $11.58 | $2.24 |
| 52 Week High | $15.50 | $12.34 |
Technical Indicators
Market Signals| Indicator | FMNB | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 38.02 | 43.04 |
| Support Level | N/A | $8.11 |
| Resistance Level | $13.76 | $8.80 |
| Average True Range (ATR) | 0.43 | 0.56 |
| MACD | -0.08 | -0.12 |
| Stochastic Oscillator | 8.97 | 11.35 |
Price Performance
Historical ComparisonAbout FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.